Epilepsy, neuropsychiatric phenotypes, neuroimaging findings, and genotype-neurophenotype correlation in 22q11.2 deletion syndrome

Abstract

Objectives: To describe the epilepsy, neuropsychiatric manifestations, and neuroimaging findings in a group of patients with 22q11.2 DS, and to correlate the size of the deleted genetic material with the severity of the phenotype. Methods: We retrospectively analyzed the medical records of 28 patients ()21 pediatric patients and 7 adults) (with a genetically confirmed diagnosis of 22q11.2 DS. Clinical data ()epilepsy, neurological exam, neuropsychological and developmental assessment, and psychiatric disorders)(, neuroimaging, and cytogenetic tests were analyzed. Results: Of the 28 patients with 22q11.2 DS, 6 21.4%) (had epileptic seizures, 2 had symptomatic hypocalcemic seizures, 4 14.2%) (had a psychiatric disorder, which comprised of attention deficit hyperactivity disorder, autism spectrum disorder, psychosis, and mood disorder, and 17 ()60.7%) (had developmental delay. All patients with epilepsy had a developmental delay. Twelve patients underwent a neuropsychology assessment. Intellectual levels ranged from moderate intellectual disability 7/12, 58%) (to average 5/12, 41.6%)(. Of the 16 patients, 6 37.5%) (had a normal brain, while 10 62.5%) (had abnormal neuroimaging findings. No significant correlation was found between the size of the deleted genetic material and the severity of the phenotype. Conclusion: 22q11.2DS patients are at high risk to develop epilepsy, neuropsychiatric manifestations, and structural brain abnormalities. This indicates that this defined genetic locus is crucial for the development of the nervous system, and patients with 22q11.2 DS have genetic susceptibility to develop epilepsy.